Inovio Pharmaceuticals, Inc.【INO】 営業利益の推移
機能の使い方
|
（単位：千ドル）
|
営業利益
|
前年比（％）
|
|
4Q25
|
-17,477
|
-14.2%
|
|
3Q25
|
-21,211
|
-22.4%
|
|
2Q25
|
-23,085
|
-30.5%
|
|
1Q25
|
-25,051
|
-20.4%
|
|
4Q24
|
-20,370
|
-25.6%
|
|
3Q24
|
-27,348
|
-23.1%
|
|
2Q24
|
-33,197
|
-10.4%
|
|
1Q24
|
-31,485
|
-28.4%
|
|
4Q23
|
-27,394
|
-51.0%
|
|
3Q23
|
-35,554
|
-0.6%
|
|
2Q23
|
-37,042
|
-64.4%
|
|
1Q23
|
-43,953
|
-38.7%
|
|
4Q22
|
-55,947
|
-47.0%
|
|
3Q22
|
-35,758
|
-40.4%
|
|
2Q22
|
-104,138
|
+25.2%
|
|
1Q22
|
-71,733
|
+36.5%
|
|
4Q21
|
-105,509
|
+259.6%
|
|
3Q21
|
-59,954
|
+65.0%
|
|
2Q21
|
-83,202
|
+150.8%
|
|
1Q21
|
-52,555
|
+108.3%
|
|
4Q20
|
-29,340
|
-3.6%
|
|
3Q20
|
-36,330
|
+51.7%
|
|
2Q20
|
-33,181
|
+17.7%
|
|
1Q20
|
-25,233
|
-11.6%
|
|
4Q19
|
-30,422
|
+3.1%
|
|
3Q19
|
-23,952
|
-10.1%
|
|
2Q19
|
-28,201
|
+442.0%
|
|
1Q19
|
-28,536
|
-12.9%
|
|
4Q18
|
-29,500
|
+28.9%
|
|
3Q18
|
-26,643
|
-8.7%
|
|
2Q18
|
-5,204
|
-46.0%
|
|
1Q18
|
-32,747
|
+49.3%
|
|
4Q17
|
-22,888
|
+2.3%
|
|
3Q17
|
-29,186
|
+44.5%
|
|
2Q17
|
-9,636
|
-47.1%
|
|
1Q17
|
-21,934
|
+42.0%
|
|
4Q16
|
-22,364
|
+53.9%
|
|
3Q16
|
-20,196
|
-641.4%
|
|
2Q16
|
-18,227
|
+20.5%
|
|
1Q16
|
-15,451
|
+84.6%
|
|
4Q15
|
-14,527
|
+31.9%
|
|
3Q15
|
3,730
|
-144.8%
|
|
2Q15
|
-15,121
|
+48.9%
|
|
1Q15
|
-8,368
|
-16.3%
|
|
4Q14
|
-11,012
|
+37.6%
|
|
3Q14
|
-8,332
|
-1188.1%
|
|
2Q14
|
-10,153
|
+79.0%
|
|
1Q14
|
-10,001
|
+50.7%
|
|
4Q13
|
-8,004
|
+28.5%
|
|
3Q13
|
765
|
-112.2%
|
|
2Q13
|
-5,673
|
-16.4%
|
|
1Q13
|
-6,635
|
+58.5%
|
|
4Q12
|
-6,228
|
+7.7%
|
|
3Q12
|
-6,292
|
-0.7%
|
|
2Q12
|
-6,788
|
+32.1%
|
|
1Q12
|
-4,187
|
-
|
|
4Q11
|
-5,780
|
-
|
|
3Q11
|
-6,337
|
-
|
|
2Q11
|
-5,137
|
-
|